Proprietary AI analyst is now available

IPOPEMA Securities Valuation Multiples

Discover IPOPEMA Securities' revenue and EBITDA valuation multiples and investment history, alongside public comparables like SBF Bostad, Skogsfond Baltikum, PEH Wertpapier, Seafire and more.

IPOPEMA Securities Overview

About IPOPEMA Securities

IPOPEMA Securities SA is focused on brokerage activities, Business and management consulting, running an investment fund company and creating and managing investment funds, Management of portfolios of brokerage financial instruments, IT management activities, and IT consulting activities. It specializes in brokerage and company analysis services, investment banking services, as well as the distribution of investment products and investment advisory services addressed to a wide range of individual investors, the creation and management of closed-end and open-end investment funds and asset management, as well as business and IT consulting services.


Founded

2005

HQ

Poland

Employees

234

Financials (FY)

Revenue: $81M
EBITDA: $11M

EV

$47M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

IPOPEMA Securities Financials

IPOPEMA Securities reported last fiscal year revenue of $81M and EBITDA of $11M.

In the same fiscal year, IPOPEMA Securities generated $7M in gross profit, $11M in EBITDA, and $7M in net income.


IPOPEMA Securities P&L

In the most recent fiscal year, IPOPEMA Securities reported revenue of $81M and EBITDA of $11M.

IPOPEMA Securities is profitable as of last fiscal year, with gross margin of 9%, EBITDA margin of 13%, and net margin of 8%.

See analyst estimates for IPOPEMA Securities
Last FY202320242025202620272028
Revenue$81M$88M$70M$81M
Gross Profit$7M$5M$2M$7M
Gross Margin9%6%3%9%
EBITDA$11M$9M$6M$11M
EBITDA Margin13%10%8%13%
EBIT Margin9%6%4%9%
Net Profit$7M$5M$2M$7M
Net Margin8%6%4%8%

Financial data powered by Morningstar, Inc.

IPOPEMA Securities Stock Performance

IPOPEMA Securities has current market cap of $55M, and enterprise value of $47M.

Market Cap Evolution


IPOPEMA Securities' stock price is $1.83.

IPOPEMA Securities share price decreased by 10.5% in the last 30 days, and increased by 149.6% in the last year.

IPOPEMA Securities has an EPS (earnings per share) of $0.22.

See more trading valuation data for IPOPEMA Securities
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$47M$55M-1.3%-10.5%21.3%149.6%$0.22

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

IPOPEMA Securities Valuation Multiples

IPOPEMA Securities trades at 0.6x EV/Revenue multiple, and 4.4x EV/EBITDA.

See NTM and 2027E valuation multiples for IPOPEMA Securities

IPOPEMA Securities Financial Valuation Multiples

As of June 13, 2026, IPOPEMA Securities has market cap of $55M and EV of $47M.

IPOPEMA Securities has a P/E ratio of 8.4x.

Last FY202320242025202620272028
EV/Revenue0.6x0.5x0.7x0.6x
EV/EBITDA4.4x5.2x8.1x4.4x
EV/EBIT6.3x8.4x17.1x6.3x
EV/Gross Profit6.6x9.0x20.4x6.6x
P/E8.4x11.0x22.0x8.4x
EV/FCF7.0x7.7x3.2x7.0x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified IPOPEMA Securities Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

IPOPEMA Securities Margins & Growth Rates

In the most recent fiscal year, IPOPEMA Securities reported gross margin of 9%, EBITDA margin of 13%, and net margin of 8%.

See estimated margins and future growth rates for IPOPEMA Securities

IPOPEMA Securities Margins

Last FY20242025202720282029
Gross Margin9%3%9%
EBITDA Margin13%8%13%
EBIT Margin9%4%9%
Net Margin8%4%8%
FCF Margin8%21%8%

IPOPEMA Securities Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(21%)15%
Gross Profit Growth(56%)209%
EBITDA Growth(37%)84%
EBIT Growth(51%)172%
Net Profit Growth(50%)162%
FCF Growth143%(55%)

Data powered by FactSet, Inc. and Morningstar, Inc.

IPOPEMA Securities Operational KPIs

IPOPEMA Securities' revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $-0.0M for the same period.

Access forward-looking KPIs for IPOPEMA Securities
Last FY202320242025202620272028
Revenue per Employee$0.3M---
Opex per Employee$-0.0M---
Opex to Revenue(0%)(0%)(1%)(0%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

IPOPEMA Securities Competitors

IPOPEMA Securities competitors include SBF Bostad, Skogsfond Baltikum, PEH Wertpapier, Seafire, FII AJ MALLS, BTCS, Mayberry Jamaican Equities, Fair Value REIT, Shareholder Value and FairPlay Properties REIT.

Most IPOPEMA Securities public comparables operate across Investment Banking, Investment Brokerage and Asset Management.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
SBF Bostad(120.9x)---
Skogsfond Baltikum2.7x---
PEH Wertpapier0.1x-1.5x-
Seafire0.7x0.7x8.7x7.6x
FII AJ MALLS74.5x---
BTCS(0.8x)(0.7x)0.4x-
Mayberry Jamaican Equities33.4x-(3.3x)-
Fair Value REIT3.6x-33.9x-

This data is available for Pro users. Sign up to see all IPOPEMA Securities competitors and their valuation data.

Start Free Trial

Investments by IPOPEMA Securities

IPOPEMA Securities has invested in 1 company to date.

Latest investment by IPOPEMA Securities was on July 25th 2017. IPOPEMA Securities invested in Braster in their $11M Series I round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by IPOPEMA Securities

Braster
Description
Braster SA offers solutions for monitoring breasts health which is an adjunct to examinations such as breast ultrasound and mammography. The system of breast examination developed for both home use by individual customers as well as professional use by healthcare professionals.
HQ CountryPoland
HQ City
Warsaw
Deal Date25 Jul 2017
RoundSeries I
Raised$11M
InvestorsIPOPEMA Securities
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all IPOPEMA Securities investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About IPOPEMA Securities

When was IPOPEMA Securities founded?IPOPEMA Securities was founded in 2005.
Where is IPOPEMA Securities headquartered?IPOPEMA Securities is headquartered in Poland.
How many employees does IPOPEMA Securities have?As of today, IPOPEMA Securities has over 234 employees.
Is IPOPEMA Securities publicly listed?Yes, IPOPEMA Securities is a public company listed on Warsaw Stock Exchange.
What is the stock symbol of IPOPEMA Securities?IPOPEMA Securities trades under IPE ticker.
When did IPOPEMA Securities go public?IPOPEMA Securities went public in 2009.
Who are competitors of IPOPEMA Securities?IPOPEMA Securities main competitors include SBF Bostad, Skogsfond Baltikum, PEH Wertpapier, Seafire, FII AJ MALLS, BTCS, Mayberry Jamaican Equities, Fair Value REIT, Shareholder Value, FairPlay Properties REIT.
What is the current market cap of IPOPEMA Securities?IPOPEMA Securities' current market cap is $55M.
What is the current revenue of IPOPEMA Securities?IPOPEMA Securities' last fiscal year revenue is $81M.
What is the current EV/Revenue multiple of IPOPEMA Securities?Current revenue multiple of IPOPEMA Securities is 0.6x.
Is IPOPEMA Securities profitable?No, IPOPEMA Securities is not profitable.
How many companies IPOPEMA Securities has acquired to date?IPOPEMA Securities hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies IPOPEMA Securities has invested to date?As of June 2026, IPOPEMA Securities has invested in 1 company.
What was the last IPOPEMA Securities investment?On 25th July 2017 IPOPEMA Securities invested in Braster, participating in a $11M Series I round.
In what companies IPOPEMA Securities invested in?IPOPEMA Securities invested in Braster.

See public comps similar to IPOPEMA Securities

Lists including IPOPEMA Securities

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial